Our study is the first to our knowledge to demonstrate abscopal effects in mice with bilateral prostate tumors treated on a single site with a combination of a STING agonist (ADU-S100) and a cytokine (cyto-IL-15). Here, IL15 is linked to prostate neoplasm.